Bcl2 is the guardian of microtubule integrity

Cancer Research

Volumn 57, Issue 2, 1997, Pages 229-233

  Haldar, Subrata ^a   Basu, Aruna ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MICROTUBULE; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CHRONIC DISEASE; G2 PHASE; HUMANS; LEUKEMIA; LYMPHOMA, B-CELL; MALE; MICROTUBULES; PACLITAXEL; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0031035693     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
2. Stewart, B. W. Mechanisms of apoptosis: integration of genetic, biochemical and cellular factors. J. Natl. Cancer Inst., 86: 1286-1295, 1994.
3. White, E. Life, death and the pursuit of apoptosis. Genes Dev. 10: 1-15, 1996.
4. Hengartner, M. O., and Horvitz, H. R. C. elegans cell survival gene Ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell, 76: 665-676, 1994.
5. Nicholson, D. W., Alo, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, Y., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.) 376: 37-43, 1995.
6. Martin, S. J., and Green, D. R. Protease activation during apoptosis. Cell, 82: 349-352, 1995.
7. Tsujimoto, Y., Finger, L., Ynis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science (Washington, DC) 226: 1097-1099, 1984.
8. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma, Science (Washington, DC) 228: 140-1443, 1985.
9. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
10. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
11. Boise, L. H., Gonzalez-Garcia, M., Postema, C. F., Ding, L., Lindstein, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. Bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 76: 597-608, 1993.
12. Oltvai, Z, Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell, 74: 609-619, 1993.
13. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Gould, B. C. Induction of apoptosis by the bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Nature (Lond.), 374: 733-736, 1995.
14. Sato, T., Hanada, M., Bodnig, S., Irie, S., Iwana, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H-G., and Reed, J. C. Interactions among members so the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994.
15. Leek, R. D., Kaklamanis, L., Pezella, F., Gatter, K. C., and Hanes, A. L. Bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor receptor-negative tumors in situ cancer. Br. J. Cancer, 69: 135-139, 1994.
16. McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J-T., Tu, S-M., and Campbell, M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.
17. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Butyan, R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol., 143: 390-400, 1993.
18. Pietenpol, J. A., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Paradoxical inhibition of solid tumor cell growth by bcl-2. Cancer Res., 54: 3714-3737, 1994.
19. Haldar, S., Jena, N., and Croce, C. M. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
20. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
21. Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
22. Rowinsky, E. K., Onetto, N., Canetta, R. M., and Arbuck, S. G. Taxol, the first of the taxanes, an important new class of antitumor agents. Senun. Oncol., 19: 648-662. 1992.
23. L, an inhibitor of programmed cell death. Nature (Lond.), 381: 335-341, 1996.
24. L and Bcl2. EMBO J., in press, 1997
25. Bullrich, F., Veronese, M. L., Kitade, S., Jurlancer, J., Caligiuri, M. A, Reed, J. C., and Croce, C. M. Minimal region of loss at 13q14 m B-CLL. Blood, 88: 3109-3115.
26. Nicolaou, K. C., Guy, R. K., and Potier, P. Taxiods: new weapons against cancer. Sci. Am., June, 94-98, 1996.
27. L and loss of p53 can cooperate to overcome in cell cycle checkpoint induced by mitotic spindle damage. Genes Dev., 10: 2621-2631, 1996.